Published 17:23 IST, March 1st 2024
Suven Pharma surges 13% on merger announcement with Cohance Lifesciences
The merger enhances Suven's position in the high-growth CDMO segment, providing multiple engines of growth through Pharma CDMO, Spec Chem CDMO, and API+.
Suven Pharma Cohance Lifesciences merger | Image:
Republic
Advertisement
11:43 IST, March 1st 2024